ANRIL is thought to be a possible oncogene in bladder cancer and positively regulates bladder cancer cell proliferation and apoptosis through the intrinsic apoptosis pathway [18]. This evidence concerns the gene CDKN2B-AS1 and urinary bladder cancer.